• 1
    Hunt N. An Overview of Models of Delivery of Drug Consumption Rooms, Paper C, Independent Working Group on Drug Consumption Rooms. York: Joseph Rowntree Foundation; 2006.
  • 2
    Hedrich D. European Report on Drug Consumption Rooms. Lisbon: EMCDDA; 2004.
  • 3
    Lloyd C., Hunt N. Drug consumption rooms: an overdue extension to harm reduction policy in the UK? Int J Drug Policy 2007; 18: 59.
  • 4
    Medically Supervised Injecting Centre Evaluation Committee. Final Report of the Evaluation of the Sydney Medically Supervised Injecting Centre. Sydney: MSIC Evaluation Committee; 2003.
  • 5
    Bayoumi A. M., Zaric G. S. The cost-effectiveness of Vancouver's supervised injecting facility. Can Med Assoc J 2008; 179: 114351.
  • 6
    Pinkerton S. D. Is Vancouver Canada's supervised injection facility cost-saving? Addiction 2010; 105: 142936.
  • 7
    Andreson M. A., Boyd N. A cost–benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. Int J Drug Policy 2010; 21: 706.
  • 8
    Health Canada. I-Track. Enhanced Surveillance of Risk Behaviours among Injecting Drug Users in Canada. 2006. Phase 1 Report. Ottawa: Public Health Agency of Canada.